Items tagged with Treatment
The Lancet: Results of Phase 2b trial of novel TB regimen PaMZ show potential to shorten, improve TB treatment (post with simple image)
Phase 3 STAND trial launched to advance PaMZ through final stage of testing.
Leading medical organizations team up to bring new TB treatments to those in need (post with simple image)
International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
MSF issue brief: Ready, set, slow down (post with simple image)
New and promising DR-TB drugs are grabbing headlines but not reaching patients.
Treating drug-sensitive TB in India: Implementation of daily therapy with fixed-dose combinations (post with simple image)
A briefing document outlines critical steps needed to implement a new policy from the Indian government to switch to standard daily TB treatment using fixed-dose combinations. This change, which is in line with global recommendations for proper treatment, is welcome but has yet to be put into action.
ECDC: Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA (post with simple image)
This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens.
The bedaquiline donation program started on April 1 (post with simple image)
A webinar, explaining the bedaquiline donation program, will be conducted on April 14, 2015 at 8:00 am EST and can be accessed here.
Nigeria spends nearly US$1.5 million for procurement of treatment for people with multidrug-resistant TB (post with simple image)
The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multidrug-resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership’s Global Drug Facility starting June 2015.
Team lands NIH funds to examine tuberculosis and metabolism (post with simple image)
A team from Colorado State University will play a crucial role in a new project funded by the National Institutes of Health to examine factors that make people susceptible to the bacterium that causes tuberculosis and to discover new treatment strategies.
How to access the bedaquiline donation program: step by step (post with simple image)
This is a note for implementers providing a general overview and reviewing the steps they need to take in order to access the drug.
Page 50 of 56 · Total posts: 0←First 49 50 51 Last→